Mesothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

A Study of Safety and Efficacy of KFA115 Alone and KFA115 in Combination With Tislelizumab in Patients With Select Advanced Cancers
Conditions:   Carcinoma, Non-Small-Cell Lung;   Cutaneous Melanoma;   Carcinoma, Renal Cell;   Carcinoma, Ovarian Epithelial;   Nasopharyngeal Carcinoma;   Carcinoma, Thymic;   Anal Cancer;   Mesothelioma;   Esophagogastric Cancer;   High Microsatellite Instability Colorectal Carcinoma;   Squamous Cell Carcinoma of Head and Neck Interventions:   Drug: KFA115;   Drug: tislelizumab Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2022 Category: Research Source Type: clinical trials